Hakan Goker, PhD, is Managing Director of M Ventures and heads the Biotechnology investments covering Healthcare and Life Sciences.
Hakan joined M Ventures in 2013 and has been investing in the sector for 15 years. Previously, Hakan was a partner at Aescap Venture investing in European opportunities. Hakan started his investment career at Atlas Venture where he was part of the investment team in London focusing on global investment opportunities in healthcare and medical technologies across US, Europe and Asia.
He was instrumental in the creation and financing, business and R&D strategies of multiple companies in their formation years including Orphazyme, Bicycle, Nimbus Discovery, and f-Star while at Aescap and Atlas.
Hakan continues his active investing role and represents M Ventures on multiple portfolio companies. He comes from an academic background receiving his Ph.D. in oncology from the Institute of Cancer Research/ University of London, UK and continuing his scientific career with post-doctoral work at the Breakthrough Breast Cancer Centre/Royal Marsden Hospital.
He gained his B.Sc. Hons, from University College London. Hakan is based in Amsterdam at the M Ventures head office.